Department of Pharmacology and Toxicology, University of Toronto, Canada.
Institute of Medical Sciences, University of Toronto, Canada.
Psychiatry Res. 2023 Jan;319:114965. doi: 10.1016/j.psychres.2022.114965. Epub 2022 Nov 19.
The Columbia Suicide Severity Rating Scale (C-SSRS) is considered the gold standard for collecting information on suicidal ideation and behavior by the Food and Drug Administration (FDA) of the United States. To determine the accuracy of the C-SSRS compared to the Beck Scale for Suicidal Ideation (BSS) for collecting suicide attempt history in the schizophrenia population, 202 participants aged 18-40 with schizophrenia spectrum disorders were administered the C-SSRS, followed by the BSS. Medical charts were reviewed to confirm the lifetime history of actual suicide attempts. The BSS had an 83.5% accuracy in reporting single suicide attempts and 81.7% for multiple suicide attempts; while the C-SSRS had 84.1% and 83.9% accuracy respectively. This difference was not statistically significant (p = 0.849). Both the BSS and C-SSRS demonstrated high sensitivity and specificity in collecting suicide attempt history for young patients with psychosis, with no significant differences. Future investigators may choose the scale that is best suited to the level of detail required.
哥伦比亚自杀严重程度评定量表(C-SSRS)被美国食品和药物管理局(FDA)视为收集自杀意念和行为信息的金标准。为了确定 C-SSRS 与贝克自杀意念量表(BSS)相比在收集精神分裂症患者自杀尝试史方面的准确性,对 202 名年龄在 18-40 岁的精神分裂症谱系障碍患者进行了 C-SSRS 测试,随后进行了 BSS 测试。审查医疗记录以确认实际自杀尝试的终生史。BSS 报告单次自杀尝试的准确率为 83.5%,多次自杀尝试的准确率为 81.7%;而 C-SSRS 的准确率分别为 84.1%和 83.9%。这一差异无统计学意义(p=0.849)。BSS 和 C-SSRS 在收集年轻精神病患者自杀尝试史方面均表现出较高的敏感性和特异性,无显著差异。未来的研究者可以选择最适合所需详细程度的量表。